Phospholipid
About Phospholipid
Phospholipid is a sterile parenteral (given directly into a vein, bypassing the digestive system) injection used to provide nutritional support for patients who cannot eat normally or cannot adequately absorb nutrients through the digestive system. It provides phospholipids and essential fatty components that can contribute to maintaining healthy cell membranes and supporting nutritional needs. This medicine is administered under medical supervision, and its use depends on the patient's nutritional and medical condition.
Because this is an injectable therapy, it is usually given on a schedule determined by your clinical team to provide the nutritional support you need. The frequency and amount of the infusion depend on your medical condition, nutritional requirements, body weight, and blood test results. Your healthcare team may also advise a suitable diet and physical activity plan according to your condition.
While receiving Phospholipid, you might experience mild side effects such as slight warmth, flushing, nausea, or minor irritation at the injection site. If you notice difficulty breathing, a rapid heartbeat, or severe dizziness during an infusion, let your healthcare team know right away, as these symptoms need prompt attention.
Do not use this medicine if you have an acute blood clot or a known allergy to any of its ingredients. Tell your doctor if you have a blood-clotting disorder, high blood lipid levels, severe kidney problems, or uncontrolled diabetes, as these conditions may require closer monitoring or adjustment of treatment.
This medicine can interact with blood thinners and may not be suitable for mixing with other intravenous medicines unless your healthcare team has checked that they can safely be given together. Tell your doctor if you regularly drink alcohol, smoke, or if you are pregnant or breastfeeding. Older adults and people receiving prolonged nutritional support may also need closer monitoring.
Uses of Phospholipid
• Respiratory Distress Syndrome Treatment: Phospholipid plays a critical role in treating Respiratory Distress Syndrome (RDS) in newborns by replacing surfactant, a substance that helps keep lungs open, thereby improving lung function and breathing.
• Improvement of Lung Function: Phospholipid improves lung function by reducing surface tension in the alveoli, enabling better gas exchange and easier breathing for newborns with RDS.
• Support in Premature Infants: Phospholipid provides crucial support to premature infants at risk of RDS, helping prevent complications associated with underdeveloped lungs and surfactant deficiency.
• Facilitation of Ventilation: Phospholipid facilitates ventilation by improving lung compliance, allowing mechanical ventilators to deliver effective breaths more easily, and supporting better oxygenation and lung function in infants.
• Reduction of Oxygen Requirements: Phospholipid helps to reduce the need for supplemental oxygen in infants with RDS by improving lung function and oxygenation, thereby supporting their respiratory health.
Medicinal Benefits
When used as directed as part of your treatment plan, Phospholipid may provide the following benefits:
- Provides nutritional support when eating is difficult: Because the medicine is given directly into a vein, it can provide nutritional components when adequate nutrition cannot be provided through normal eating or the digestive system.
- Supplies essential fatty components: The phospholipids and fatty components provide building blocks that the body can use for normal cell membrane structure and function.
- Supports nutritional recovery: Providing appropriate nutritional components can help support the body's nutritional needs during illness, recovery, or periods when normal food intake is inadequate.
Directions for Use
- Follow your doctor's instructions on the dosage and timing of this medication.
- Phospholipid is administered by the doctor or healthcare professional.
- Do not self-administer.
Storage
Side Effects of Phospholipid
Common Side Effects (Usually mild):
- Slight pain, redness, warmth, or irritation at the injection site
- Nausea or mild stomach discomfort
- A temporary oily taste in the mouth during infusion
- Mild headache or feeling slightly flushed
Serious Side Effects (Consult your doctor right away):
- Signs of a severe allergic reaction, such as swelling of the face, lips, or throat, severe skin rash, or difficulty breathing
- Wheezing, chest tightness, or other breathing difficulties
- High fever, chills, or shaking
- Sudden swelling in the legs or unexplained shortness of breath, which may require urgent assessment
Drug Warnings
- Check the infusion before use: Do not use the product if the liquid shows unexpected oil droplets, separation, particles, or discoloration.
- Follow the prescribed infusion rate: Do not change the infusion speed yourself. A rate that is too fast may increase the risk of complications.
- Keep your IV site clean: Follow the sterile technique taught by your healthcare team and tell them if the area becomes painful, swollen, warm, or red.
- Keep up with blood tests: Your doctor may monitor liver function, triglyceride or other blood lipid levels, blood glucose, and electrolyte balance to make sure your body is tolerating the nutritional therapy. Monitoring of triglycerides is particularly important with intravenous lipid therapy.
- Watch for infection: Tell your healthcare provider about fever, chills, increasing redness, warmth, swelling, or discharge around the IV access site, as these may indicate an infection.
- Tell your doctor about blood-clotting problems: A history of a blood-clotting disorder is different from having an active blood clot. Your doctor will assess your individual risk before deciding whether this medicine is appropriate.
- Avoid use with an acute blood clot: Tell your doctor if you have an active or recent blood clot, as intravenous lipid therapy may not be appropriate in this situation.
- Children need specialist supervision: Phospholipid-containing intravenous lipid emulsions can be used in paediatric and neonatal nutritional support in appropriate clinical settings, but the dose, infusion rate, and monitoring must be individually determined by a paediatric or neonatal care team.
- Tell your healthcare team about new symptoms: If you notice difficulty breathing, a rapid heartbeat, or severe dizziness during an infusion, let your healthcare team know right away; these symptoms need prompt attention.
Drug Interactions
- Blood thinners (e.g., warfarin): Tell your doctor if you take blood-thinning medicines. Your treatment may require closer monitoring because changes in nutritional therapy or lipid metabolism can affect your overall bleeding or clotting management.
- Other intravenous medicines: Do not mix Phospholipid with another medicine in the same intravenous line unless your pharmacist or doctor has checked that the two medicines can safely be given together. Compatibility can vary between products and formulations.
Drug-Drug Interactions Checker List:
Safety Advice
Alcohol
not applicableNot applicable
Pregnancy
not applicableNot applicable
Breast Feeding
not applicableNot applicable
Driving
not applicableNot applicable
Liver
cautionIf your
Kidney
consult your doctorConsult your doctor If your baby has any kidney impairments before administering Phospholipid.
Children
safePhospholipid is given for the new born babies.
Habit Forming
Diet & Lifestyle Advise
- Follow your nutrition plan: Follow the diet recommended by your doctor or dietitian, particularly if Phospholipid is being used as part of nutritional support.
- Limit alcohol: Avoid or limit alcohol if your healthcare team advises this, particularly if you have liver disease or are receiving nutritional support for a liver-related condition.
- Stay hydrated: Drink enough water unless your healthcare team has advised you to restrict fluids.
- Stay active when appropriate: Gentle, low-impact activity such as walking may support general strength and recovery when approved by your doctor.
Patients Concern
Disease/Condition Glossary
NRDS: Neonatal Respiratory Distress Syndrome (NRDS/Hyaline Membrane Disease) occurs when a baby's lungs are not fully developed and cannot provide enough oxygen, causing breathing difficulties. It usually affects premature babies. It's also known as infant respiratory distress syndrome, hyaline membrane disease, or surfactant deficiency lung disease. The symptoms of NRDS are blue-coloured lips, fingers, and toes, rapid, shallow breathing, flaring nostrils, and a grunting sound when breathing.
FAQs
In some cases, Phospholipid may cause side effects such as patent ductus arteriosus, decreased post-dose pulmonary function values, intraventricular haemorrhage of all grades, infection throughout the body (sepsis), retinopathy of prematurity, bradycardia, severe intraventricular haemorrhage. However, after giving Phospholipid, the doctor will closely monitor the baby's health status. If any adverse effects occur, your doctor will take the necessary action for your baby.
Phospholipid works by providing the (phospholipid) bovine lipid extract surfactant to the lungs of newborn babies with NRDS; it spreads through the lungs, allowing the lungs to expand properly and oxygen to enter the blood more easily. This will lower the baby’s need for extra oxygen under pressure and make breathing easier.
Phospholipid is in the dosage form of suspension for intratracheal instillation.
Phospholipid is an injectable nutritional support medicine that provides phospholipids and fatty components directly into the bloodstream. It may be used when adequate nutrition cannot be provided through normal eating or digestion and absorption. Your doctor will decide whether it is appropriate for your nutritional and medical needs.
Phospholipid is given directly into a vein as an infusion. It is usually administered by a healthcare professional in a hospital, clinic, or appropriately supervised home-care setting. Your healthcare team will determine the dose and infusion rate.
Intravenous lipid emulsions can be used as part of nutritional support in children and newborns when clinically appropriate. However, children and especially premature or critically ill newborns require carefully calculated doses and close monitoring of triglycerides, electrolytes, liver function, and other nutritional parameters.
Mild redness, warmth, or discomfort can occur around an IV site. However, increasing pain, swelling, warmth, redness, or discharge should be reported to your healthcare provider because these symptoms may indicate vein irritation or an infection.
